Filed: 11/13/2023ACC: 0001697228-23-000004
📋 What this filing means
UNIVERSITY OF WISCONSIN FOUNDATION filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $87.26M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$87.26M
Total AUM (reported)
2.32M
Total Shares
Allocation by class
CORE S&P500 ET$60.36M69.2%
ORD SHS CL A$13.84M15.9%
COM$13.07M15.0%
Portfolio Concentration
Top 3$80.06M91.7%
4–10$7.20M8.3%
Top 3 weight
91.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.32M
Sole
Full voting authority
2.32M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ISHARES TR
SOLEShares140.55K
TypeSH
Market value$60.36M
69.16%
Sole
140.55K
Shared
0.00
None
0.00
NU HLDGS LTD
SOLEShares1.91M
TypeSH
Market value$13.84M
15.86%
Sole
1.91M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares40.13K
TypeSH
Market value$5.86M
6.72%
Sole
40.13K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares103.82K
TypeSH
Market value$5.25M
6.02%
Sole
103.82K
Shared
0.00
None
0.00
89BIO INC
SOLEShares126.52K
TypeSH
Market value$1.95M
2.24%
Sole
126.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ISHARES TRSOLE | CORE S&P500 ET | 140.55K | SH | $60.36M 69.16% | 140.55K | 0.00 | 0.00 |
NU HLDGS LTDSOLE | ORD SHS CL A | 1.91M | SH | $13.84M 15.86% | 1.91M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 40.13K | SH | $5.86M 6.72% | 40.13K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 103.82K | SH | $5.25M 6.02% | 103.82K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 126.52K | SH | $1.95M 2.24% | 126.52K | 0.00 | 0.00 |